Global Dermatology Drug Market Insights and Forecast to 2027

Global Dermatology Drug Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Dermatology Drug Product Introduction
1.2 Market by Type
1.2.1 Global Dermatology Drug Market Size Growth Rate by Type
1.4.2 External Use
1.4.3 Oral
1.2.4 Injection
1.3 Market by Application
1.3.1 Global Dermatology Drug Market Size Growth Rate by Application
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermatology Drug Sales Estimates and Forecasts 2016-2027
2.2 Global Dermatology Drug Revenue Estimates and Forecasts 2016-2027
2.3 Global Dermatology Drug Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Dermatology Drug Regions by Sales
2.4.1 Global Top Dermatology Drug Regions by Sales (2016-2021)
2.4.2 Global Top Dermatology Drug Regions by Sales (2022-2027)
2.5 Global Top Dermatology Drug Regions by Revenue
2.5.1 Global Top Dermatology Drug Regions by Revenue (2016-2021)
2.5.2 Global Top Dermatology Drug Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dermatology Drug Sales by Manufacturers
3.1.1 Global Top Dermatology Drug Manufacturers by Sales (2016-2021)
3.1.2 Global Top Dermatology Drug Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Dermatology Drug Sales in 2020
3.2 Global Dermatology Drug Revenue by Manufacturers
3.2.1 Global Top Dermatology Drug Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Dermatology Drug Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Dermatology Drug Revenue in 2020
3.3 Global Dermatology Drug Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dermatology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dermatology Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dermatology Drug Sales by Type
4.1.1 Global Dermatology Drug Historical Sales by Type (2016-2021)
4.1.2 Global Dermatology Drug Forecasted Sales by Type (2022-2027)
4.1.3 Global Dermatology Drug Sales Market Share by Type (2016-2027)
4.2 Global Dermatology Drug Revenue by Type
4.2.1 Global Dermatology Drug Historical Revenue by Type (2016-2021)
4.2.2 Global Dermatology Drug Forecasted Revenue by Type (2022-2027)
4.2.3 Global Dermatology Drug Revenue Market Share by Type (2016-2027)
4.3 Global Dermatology Drug Price by Type
4.3.1 Global Dermatology Drug Price by Type (2016-2021)
4.3.2 Global Dermatology Drug Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Dermatology Drug Sales by Application
5.1.1 Global Dermatology Drug Historical Sales by Application (2016-2021)
5.1.2 Global Dermatology Drug Forecasted Sales by Application (2022-2027)
5.1.3 Global Dermatology Drug Sales Market Share by Application (2016-2027)
5.2 Global Dermatology Drug Revenue by Application
5.2.1 Global Dermatology Drug Historical Revenue by Application (2016-2021)
5.2.2 Global Dermatology Drug Forecasted Revenue by Application (2022-2027)
5.2.3 Global Dermatology Drug Revenue Market Share by Application (2016-2027)
5.3 Global Dermatology Drug Price by Application
5.3.1 Global Dermatology Drug Price by Application (2016-2021)
5.3.2 Global Dermatology Drug Price Forecast by Application (2022-2027)
6 North America
6.1 North America Dermatology Drug Market Size by Type
6.1.1 North America Dermatology Drug Sales by Type (2016-2027)
6.1.2 North America Dermatology Drug Revenue by Type (2016-2027)
6.2 North America Dermatology Drug Market Size by Application
6.2.1 North America Dermatology Drug Sales by Application (2016-2027)
6.2.2 North America Dermatology Drug Revenue by Application (2016-2027)
6.3 North America Dermatology Drug Market Size by Country
6.3.1 North America Dermatology Drug Sales by Country (2016-2027)
6.3.2 North America Dermatology Drug Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dermatology Drug Market Size by Type
7.1.1 Europe Dermatology Drug Sales by Type (2017-2027)
7.1.2 Europe Dermatology Drug Revenue by Type (2017-2027)
7.2 Europe Dermatology Drug Market Size by Application
7.2.1 Europe Dermatology Drug Sales by Application (2017-2027)
7.2.2 Europe Dermatology Drug Revenue by Application (2017-2027)
7.3 Europe Dermatology Drug Market Size by Country
7.3.1 Europe Dermatology Drug Sales by Country (2017-2027)
7.3.2 Europe Dermatology Drug Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dermatology Drug Market Size by Type
8.1.1 Asia Pacific Dermatology Drug Sales by Type (2018-2027)
8.1.2 Asia Pacific Dermatology Drug Revenue by Type (2018-2027)
8.2 Asia Pacific Dermatology Drug Market Size by Application
8.2.1 Asia Pacific Dermatology Drug Sales by Application (2018-2027)
8.2.2 Asia Pacific Dermatology Drug Revenue by Application (2018-2027)
8.3 Asia Pacific Dermatology Drug Market Size by Region
8.3.1 Asia Pacific Dermatology Drug Sales by Region (2018-2027)
8.3.2 Asia Pacific Dermatology Drug Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dermatology Drug Market Size by Type
9.1.1 Latin America Dermatology Drug Sales by Type (2019-2027)
9.1.2 Latin America Dermatology Drug Revenue by Type (2019-2027)
9.2 Latin America Dermatology Drug Market Size by Application
9.2.1 Latin America Dermatology Drug Sales by Application (2019-2027)
9.2.2 Latin America Dermatology Drug Revenue by Application (2019-2027)
9.3 Latin America Dermatology Drug Market Size by Country
9.3.1 Latin America Dermatology Drug Sales by Country (2019-2027)
9.3.2 Latin America Dermatology Drug Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Dermatology Drug Market Size by Type
6.1.1 Middle East and Africa Dermatology Drug Sales by Type (2016-2027)
6.1.2 Middle East and Africa Dermatology Drug Revenue by Type (2016-2027)
6.2 Middle East and Africa Dermatology Drug Market Size by Application
6.2.1 Middle East and Africa Dermatology Drug Sales by Application (2016-2027)
6.2.2 Middle East and Africa Dermatology Drug Revenue by Application (2016-2027)
6.3 Middle East and Africa Dermatology Drug Market Size by Country
6.3.1 Middle East and Africa Dermatology Drug Sales by Country (2016-2027)
6.3.2 Middle East and Africa Dermatology Drug Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AbbVie Dermatology Drug Product Description
11.1.5 AbbVie Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Johnson & Johnson Dermatology Drug Product Description
11.2.5 Johnson & Johnson Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Bayer Dermatology Drug Product Description
11.3.5 Bayer Related Developments
11.4 Galderma
11.4.1 Galderma Corporation Information
11.4.2 Galderma Overview
11.4.3 Galderma Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Galderma Dermatology Drug Product Description
11.4.5 Galderma Related Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Overview
11.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Bristol-Myers Squibb Dermatology Drug Product Description
11.5.5 Bristol-Myers Squibb Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Novartis Dermatology Drug Product Description
11.6.5 Novartis Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Pfizer Dermatology Drug Product Description
11.7.5 Pfizer Related Developments
11.8 Merz Pharma
11.8.1 Merz Pharma Corporation Information
11.8.2 Merz Pharma Overview
11.8.3 Merz Pharma Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Merz Pharma Dermatology Drug Product Description
11.8.5 Merz Pharma Related Developments
11.9 Valeant
11.9.1 Valeant Corporation Information
11.9.2 Valeant Overview
11.9.3 Valeant Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Valeant Dermatology Drug Product Description
11.9.5 Valeant Related Developments
11.10 LEO Pharma
11.10.1 LEO Pharma Corporation Information
11.10.2 LEO Pharma Overview
11.10.3 LEO Pharma Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 LEO Pharma Dermatology Drug Product Description
11.10.5 LEO Pharma Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Dermatology Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AbbVie Dermatology Drug Product Description
11.1.5 AbbVie Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Dermatology Drug Value Chain Analysis
12.2 Dermatology Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermatology Drug Production Mode & Process
12.4 Dermatology Drug Sales and Marketing
12.4.1 Dermatology Drug Sales Channels
12.4.2 Dermatology Drug Distributors
12.5 Dermatology Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dermatology Drug Industry Trends
13.2 Dermatology Drug Market Drivers
13.3 Dermatology Drug Market Challenges
13.4 Dermatology Drug Market Restraints
14 Key Findings in The Global Dermatology Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dermatology Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of External Use
Table 3. Major Manufacturers of Oral
Table 4. Major Manufacturers of Injection
Table 5. Global Dermatology Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Dermatology Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Dermatology Drug Sales by Region (2016-2021) & (K Units)
Table 8. Global Dermatology Drug Sales Market Share by Region (2016-2021)
Table 9. Global Dermatology Drug Sales by Region (2016-2021) & (K Units)
Table 10. Global Dermatology Drug Sales Market Share by Region (2022-2027)
Table 11. Global Dermatology Drug Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Dermatology Drug Revenue Market Share by Region (2016-2021)
Table 13. Global Dermatology Drug Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Dermatology Drug Revenue Market Share by Region (2022-2027)
Table 15. Global Dermatology Drug Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Dermatology Drug Sales Share by Manufacturers (2016-2021)
Table 17. Global Dermatology Drug Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Dermatology Drug Revenue Share by Manufacturers (2016-2021)
Table 19. Dermatology Drug Price by Manufacturers 2016-2021 (USD/Unit)
Table 20. Global Dermatology Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Dermatology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology Drug as of 2020)
Table 22. Dermatology Drug Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Dermatology Drug Product Offered
Table 24. Date of Manufacturers Enter into Dermatology Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 27. Global Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 28. Global Dermatology Drug Sales Share by Type (2016-2021)
Table 29. Global Dermatology Drug Sales Share by Type (2022-2027)
Table 30. Global Dermatology Drug Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Dermatology Drug Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Dermatology Drug Revenue Share by Type (2016-2021)
Table 33. Global Dermatology Drug Revenue Share by Type (2022-2027)
Table 34. Dermatology Drug Price by Type (2016-2021) & (USD/Unit)
Table 35. Global Dermatology Drug Price Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 37. Global Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 38. Global Dermatology Drug Sales Share by Application (2016-2021)
Table 39. Global Dermatology Drug Sales Share by Application (2022-2027)
Table 40. Global Dermatology Drug Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Dermatology Drug Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Dermatology Drug Revenue Share by Application (2016-2021)
Table 43. Global Dermatology Drug Revenue Share by Application (2022-2027)
Table 44. Dermatology Drug Price by Application (2016-2021) & (USD/Unit)
Table 45. Global Dermatology Drug Price Forecast by Application (2022-2027) & (USD/Unit)
Table 46. North America Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 47. North America Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 48. North America Dermatology Drug Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Dermatology Drug Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 51. North America Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 52. North America Dermatology Drug Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Dermatology Drug Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Dermatology Drug Sales by Country (2016-2021) & (K Units)
Table 55. North America Dermatology Drug Sales by Country (2022-2027) & (K Units)
Table 56. North America Dermatology Drug Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Dermatology Drug Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 59. Europe Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 60. Europe Dermatology Drug Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Dermatology Drug Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 63. Europe Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 64. Europe Dermatology Drug Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Dermatology Drug Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Dermatology Drug Sales by Country (2016-2021) & (K Units)
Table 67. Europe Dermatology Drug Sales by Country (2022-2027) & (K Units)
Table 68. Europe Dermatology Drug Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Dermatology Drug Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Dermatology Drug Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Dermatology Drug Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Dermatology Drug Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Dermatology Drug Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Dermatology Drug Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Dermatology Drug Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Dermatology Drug Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Dermatology Drug Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Dermatology Drug Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Dermatology Drug Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Dermatology Drug Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Dermatology Drug Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Dermatology Drug Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Dermatology Drug Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Dermatology Drug Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Dermatology Drug Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Dermatology Drug Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Dermatology Drug Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Dermatology Drug Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Dermatology Drug Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Dermatology Drug Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Dermatology Drug Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Dermatology Drug Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Dermatology Drug Revenue by Country (2022-2027) & (US$ Million)
Table 106. AbbVie Corporation Information
Table 107. AbbVie Description and Major Businesses
Table 108. AbbVie Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 109. AbbVie Dermatology Drug Product
Table 110. AbbVie Recent Developments
Table 111. Johnson & Johnson Corporation Information
Table 112. Johnson & Johnson Description and Major Businesses
Table 113. Johnson & Johnson Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Johnson & Johnson Dermatology Drug Product
Table 115. Johnson & Johnson Recent Developments
Table 116. Bayer Corporation Information
Table 117. Bayer Description and Major Businesses
Table 118. Bayer Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. Bayer Dermatology Drug Product
Table 120. Bayer Recent Developments
Table 121. Galderma Corporation Information
Table 122. Galderma Description and Major Businesses
Table 123. Galderma Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. Galderma Dermatology Drug Product
Table 125. Galderma Recent Developments
Table 126. Bristol-Myers Squibb Corporation Information
Table 127. Bristol-Myers Squibb Description and Major Businesses
Table 128. Bristol-Myers Squibb Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Bristol-Myers Squibb Dermatology Drug Product
Table 130. Bristol-Myers Squibb Recent Developments
Table 131. Novartis Corporation Information
Table 132. Novartis Description and Major Businesses
Table 133. Novartis Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 134. Novartis Dermatology Drug Product
Table 135. Novartis Recent Developments
Table 136. Pfizer Corporation Information
Table 137. Pfizer Description and Major Businesses
Table 138. Pfizer Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 139. Pfizer Dermatology Drug Product
Table 140. Pfizer Recent Developments
Table 141. Merz Pharma Corporation Information
Table 142. Merz Pharma Description and Major Businesses
Table 143. Merz Pharma Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 144. Merz Pharma Dermatology Drug Product
Table 145. Merz Pharma Recent Developments
Table 146. Valeant Corporation Information
Table 147. Valeant Description and Major Businesses
Table 148. Valeant Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 149. Valeant Dermatology Drug Product
Table 150. Valeant Recent Developments
Table 151. LEO Pharma Corporation Information
Table 152. LEO Pharma Description and Major Businesses
Table 153. LEO Pharma Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 154. LEO Pharma Dermatology Drug Product
Table 155. LEO Pharma Recent Developments
Table 156. GlaxoSmithKline Corporation Information
Table 157. GlaxoSmithKline Description and Major Businesses
Table 158. GlaxoSmithKline Dermatology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 159. GlaxoSmithKline Dermatology Drug Product
Table 160. GlaxoSmithKline Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Dermatology Drug Distributors List
Table 164. Dermatology Drug Customers List
Table 165. Dermatology Drug Market Trends
Table 166. Dermatology Drug Market Drivers
Table 167. Dermatology Drug Market Challenges
Table 168. Dermatology Drug Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatology Drug Product Picture
Figure 2. Global Dermatology Drug Market Share by Type in 2020 & 2027
Figure 3. External Use Product Picture
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Dermatology Drug Sales Market Share by Application in 2020 & 2027
Figure 7. Psoriasis
Figure 8. Skin Infections
Figure 9. Acne
Figure 10. Dermatitis
Figure 11. Others
Figure 12. Dermatology Drug Report Years Considered
Figure 13. Global Dermatology Drug Sales 2016-2027 (K Units)
Figure 14. Global Dermatology Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Dermatology Drug Revenue 2016-2027 (US$ Million)
Figure 16. Global Dermatology Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Dermatology Drug Sales Market Share by Region (2016-2021)
Figure 18. Global Dermatology Drug Sales Market Share by Region (2022-2027)
Figure 19. North America Dermatology Drug Sales YoY (2016-2027) & (K Units)
Figure 20. North America Dermatology Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Dermatology Drug Sales YoY (2016-2027) & (K Units)
Figure 22. Europe Dermatology Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Dermatology Drug Sales YoY (2016-2027) & (K Units)
Figure 24. Asia-Pacific Dermatology Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Dermatology Drug Sales YoY (2016-2027) & (K Units)
Figure 26. Latin America Dermatology Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Dermatology Drug Sales YoY (2016-2027) & (K Units)
Figure 28. Middle East & Africa Dermatology Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Dermatology Drug Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Dermatology Drug Revenue in 2020
Figure 31. Dermatology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Dermatology Drug Sales Market Share by Type (2016-2027)
Figure 33. Global Dermatology Drug Revenue Market Share by Type (2016-2027)
Figure 34. Global Dermatology Drug Sales Market Share by Application (2016-2027)
Figure 35. Global Dermatology Drug Revenue Market Share by Application (2016-2027)
Figure 36. North America Dermatology Drug Sales Market Share by Type (2016-2027)
Figure 37. North America Dermatology Drug Revenue Market Share by Type (2016-2027)
Figure 38. North America Dermatology Drug Sales Market Share by Application (2016-2027)
Figure 39. North America Dermatology Drug Revenue Market Share by Application (2016-2027)
Figure 40. North America Dermatology Drug Sales Share by Country (2016-2027)
Figure 41. North America Dermatology Drug Revenue Share by Country (2016-2027)
Figure 42. U.S. Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Dermatology Drug Sales Market Share by Type (2016-2027)
Figure 45. Europe Dermatology Drug Revenue Market Share by Type (2016-2027)
Figure 46. Europe Dermatology Drug Sales Market Share by Application (2016-2027)
Figure 47. Europe Dermatology Drug Revenue Market Share by Application (2016-2027)
Figure 48. Europe Dermatology Drug Sales Share by Country (2016-2027)
Figure 49. Europe Dermatology Drug Revenue Share by Country (2016-2027)
Figure 50. Germany Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 51. France Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Dermatology Drug Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Dermatology Drug Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Dermatology Drug Sales Market Share by Application (2016-2027)
Figure 58. Asia Pacific Dermatology Drug Revenue Market Share by Application (2016-2027)
Figure 59. Asia Pacific Dermatology Drug Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Dermatology Drug Revenue Share by Region (2016-2027)
Figure 61. China Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 64. India Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 66. Taiwan Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 70. Philippines Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 71. Latin America Dermatology Drug Sales Market Share by Type (2016-2027)
Figure 72. Latin America Dermatology Drug Revenue Market Share by Type (2016-2027)
Figure 73. Latin America Dermatology Drug Sales Market Share by Application (2016-2027)
Figure 74. Latin America Dermatology Drug Revenue Market Share by Application (2016-2027)
Figure 75. Latin America Dermatology Drug Sales Share by Country (2016-2027)
Figure 76. Latin America Dermatology Drug Revenue Share by Country (2016-2027)
Figure 77. Mexico Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 78. Brazil Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 79. Argentina Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 80. Middle East and Africa Dermatology Drug Sales Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Dermatology Drug Revenue Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Dermatology Drug Sales Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Dermatology Drug Revenue Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Dermatology Drug Sales Share by Country (2016-2027)
Figure 85. Middle East and Africa Dermatology Drug Revenue Share by Country (2016-2027)
Figure 86. Turkey Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 87. Saudi Arabia Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 88. U.A.E Dermatology Drug Revenue (2016-2027) & (US$ Million)
Figure 89. Dermatology Drug Value Chain
Figure 90. Dermatology Drug Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Hyaluronic Acid Dermal Filler Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 88

Hyaluronic Acid Dermal Filler are The product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour. The global Hyaluronic Acid Dermal Filler market was valued at US$ 2682.8 million in 2023 and is anticipated to reach US$ 5035.7 million by 2030, witnessing a CAGR of 9.3% during The forecast period 2024-2030. The producers mainly located in Europe, United States, China and Korea, such as Allergan,......

Global Hyaluronic Acid Based Dermal Fillers Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Hyaluronic Acid Based Dermal Fillers market size was valued at US$ 2195.2 million in 2023. With growing demand in downstream market, the Hyaluronic Acid Based Dermal Fillers is forecast to a readjusted size of US$ 3708.9 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Hyaluronic Acid Based Dermal Fillers market. Hyaluronic Acid Based Dermal Fillers ar......

Global Dermal Fillers Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Dermal Fillers market size was valued at US$ 5342.2 million in 2023. With growing demand in downstream market, the Dermal Fillers is forecast to a readjusted size of US$ 15850 million by 2030 with a CAGR of 16.8% during review period. The research report highlights the growth potential of the global Dermal Fillers market. Dermal Fillers are expected to show stable growth in the future market. However, product differentiation,......

Global Hyaluronic Acid Dermal Filler Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Hyaluronic Acid Dermal Filler market size was valued at US$ 2624.4 million in 2023. With growing demand in downstream market, the Hyaluronic Acid Dermal Filler is forecast to a readjusted size of US$ 5000.7 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Hyaluronic Acid Dermal Filler market. Hyaluronic Acid Dermal Filler are expected to show stable gr......

Global Pressure Ulcer Treatment Products Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Pressure Ulcer Treatment Products market size was valued at US$ 2150.3 million in 2023. With growing demand in downstream market, the Pressure Ulcer Treatment Products is forecast to a readjusted size of US$ 3021.5 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Pressure Ulcer Treatment Products market. Pressure Ulcer Treatment Products are expected t......

Global Dermatology Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108

According to our LPI (LP Information) latest study, the global Dermatology Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Dermatology Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Dermatology Drug market. Dermatology Drug are expected to show stable growth in the future market. However, product differentiation, reducing ......

Global Pruritus Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Pruritus Therapeutics market size was valued at US$ 13380 million in 2023. With growing demand in downstream market, the Pruritus Therapeutics is forecast to a readjusted size of US$ 17790 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Pruritus Therapeutics market. Pruritus Therapeutics are expected to show stable growth in the future market. However......

Global Scar Treatment Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Scar Treatment market size was valued at US$ 956.9 million in 2023. With growing demand in downstream market, the Scar Treatment is forecast to a readjusted size of US$ 1584.4 million by 2030 with a CAGR of 7.5% during review period. The research report highlights the growth potential of the global Scar Treatment market. Scar Treatment are expected to show stable growth in the future market. However, product differentiation, ......

Global Botox Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92

According to our LPI (LP Information) latest study, the global Botox market size was valued at US$ 4597.8 million in 2023. With growing demand in downstream market, the Botox is forecast to a readjusted size of US$ 9055 million by 2030 with a CAGR of 10.2% during review period. The research report highlights the growth potential of the global Botox market. Botox are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain opt......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs